Loading…

Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias

Electrical cardioversion (ECV) is recommended for rhythm control in patients with atrial arrhythmia; yet, ECV use and outcomes in contemporary practice are unknown. We reviewed all nonemergent ECVs for atrial arrhythmias at a tertiary care center (2010 to 2013), stratifying patients by transesophage...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2015-05, Vol.115 (10), p.1407-1414
Main Authors: Steinberg, Benjamin Adam, MD, MHS, Schulte, Phillip Joel, PhD, Hofmann, Paul, BS, Ersbøll, Mads, MD, Alexander, John Hunter, MD, MHS, Broderick-Forsgren, Kathleen, MD, Anstrom, Kevin Joseph, PhD, Granger, Christopher Bull, MD, Piccini, Jonathan Paul, MD, MHS, Velazquez, Eric Jose, MD, Shah, Bimal Ramesh, MD, MBA
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3
cites cdi_FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3
container_end_page 1414
container_issue 10
container_start_page 1407
container_title The American journal of cardiology
container_volume 115
creator Steinberg, Benjamin Adam, MD, MHS
Schulte, Phillip Joel, PhD
Hofmann, Paul, BS
Ersbøll, Mads, MD
Alexander, John Hunter, MD, MHS
Broderick-Forsgren, Kathleen, MD
Anstrom, Kevin Joseph, PhD
Granger, Christopher Bull, MD
Piccini, Jonathan Paul, MD, MHS
Velazquez, Eric Jose, MD
Shah, Bimal Ramesh, MD, MBA
description Electrical cardioversion (ECV) is recommended for rhythm control in patients with atrial arrhythmia; yet, ECV use and outcomes in contemporary practice are unknown. We reviewed all nonemergent ECVs for atrial arrhythmias at a tertiary care center (2010 to 2013), stratifying patients by transesophageal echocardiography (TEE) use before ECV and comparing demographics, history, vitals, and laboratory studies. Outcomes included postprocedural success and complications and repeat cardioversion, rehospitalization, and death within 30 days. Overall, 1,017 patients underwent ECV, 760 (75%) for atrial fibrillation and 240 (24%) for atrial flutter; 633 underwent TEE before ECV and 384 did not. TEE recipients were more likely to be inpatients (74% vs 44%, p
doi_str_mv 10.1016/j.amjcard.2015.02.030
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1677379369</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002914915007262</els_id><sourcerecordid>3688538991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EosvCI4Aiceklqcex4_hStFoVaFXRA3C2vM6EOk3iYieV9u1xtEsr9dKTZc03M_b3E_IRaAEUqrOuMENnTWgKRkEUlBW0pK_ICmqpclBQviYrSinLFXB1Qt7F2KUrgKjekhMmZM0F8BW5upkn6weM2aadMGQ__IgDhj84TtlFj3YKzpo-26ZFzj9giM6PWetDtkmVVNiEcLufbgdn4nvypjV9xA_Hc01-f734tf2eX998u9xurnMrKjHlqJQs0TRUcaQcGstaA4zZVlY1NKoVtQEqdqoSZSvUjpsGOCbK7oBLI7Fck9PD3Pvg_84YJz24aLHvzYh-jhoqKUupykol9PMztPNzGNPrElWD4LJOa9ZEHCgbfIwBW30f3GDCXgPVi2zd6aNsvcjWlOkkO_V9Ok6fdwM2j13_7SbgywHApOPBYdDROhwtNi4ktbrx7sUV588m2N6NSyR3uMf49BsdU4P-uSS-BA6CUskqVv4Du-CnEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1681547865</pqid></control><display><type>article</type><title>Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias</title><source>ScienceDirect Journals</source><creator>Steinberg, Benjamin Adam, MD, MHS ; Schulte, Phillip Joel, PhD ; Hofmann, Paul, BS ; Ersbøll, Mads, MD ; Alexander, John Hunter, MD, MHS ; Broderick-Forsgren, Kathleen, MD ; Anstrom, Kevin Joseph, PhD ; Granger, Christopher Bull, MD ; Piccini, Jonathan Paul, MD, MHS ; Velazquez, Eric Jose, MD ; Shah, Bimal Ramesh, MD, MBA</creator><creatorcontrib>Steinberg, Benjamin Adam, MD, MHS ; Schulte, Phillip Joel, PhD ; Hofmann, Paul, BS ; Ersbøll, Mads, MD ; Alexander, John Hunter, MD, MHS ; Broderick-Forsgren, Kathleen, MD ; Anstrom, Kevin Joseph, PhD ; Granger, Christopher Bull, MD ; Piccini, Jonathan Paul, MD, MHS ; Velazquez, Eric Jose, MD ; Shah, Bimal Ramesh, MD, MBA</creatorcontrib><description>Electrical cardioversion (ECV) is recommended for rhythm control in patients with atrial arrhythmia; yet, ECV use and outcomes in contemporary practice are unknown. We reviewed all nonemergent ECVs for atrial arrhythmias at a tertiary care center (2010 to 2013), stratifying patients by transesophageal echocardiography (TEE) use before ECV and comparing demographics, history, vitals, and laboratory studies. Outcomes included postprocedural success and complications and repeat cardioversion, rehospitalization, and death within 30 days. Overall, 1,017 patients underwent ECV, 760 (75%) for atrial fibrillation and 240 (24%) for atrial flutter; 633 underwent TEE before ECV and 384 did not. TEE recipients were more likely to be inpatients (74% vs 44%, p &lt;0.001), have higher mean CHADS2 scores (2.6 vs 2.4, p = 0.03), and lower mean international normalized ratios (1.2 vs 2.1, p &lt;0.001). Overall, 89 patients (8.8%) did not achieve sinus rhythm and 14 experienced procedural complications (1.4%). Within 30 days, 80 patients (7.9%) underwent repeat ECV, 113 (11%) were rehospitalized, and 14 (1.4%) died. Although ECV success was more common in patients who underwent TEE before ECV (77% vs 68%, p = 0.01), there were no differences in 30-day death or rehospitalization rates (11.1% vs 13.0%, p = 0.37). In multivariate analyses, higher pre-ECV heart rate was associated with increased rehospitalization or death (adjusted hazard ratio 1.15/10 beats/min, 95% confidence interval 1.07 to 1.24, p &lt;0.001), whereas TEE use was associated with lower rates (adjusted hazard ratio 0.58, 95% confidence interval 0.39 to 0.86, p = 0.007). In conclusion, failures, complications, and rehospitalization after nonemergent ECV are common and associated more with patient condition than procedural characteristics. TEE use was associated with better clinical outcomes.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2015.02.030</identifier><identifier>PMID: 25784514</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Age ; Aged ; Atrial Fibrillation - diagnostic imaging ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - therapy ; Blood pressure ; Cardiac arrhythmia ; Cardiovascular ; Cardiovascular disease ; Clinical outcomes ; Confidence intervals ; Diabetes ; Echocardiography, Transesophageal ; Electric Countershock - methods ; Emergencies ; Family medical history ; Female ; Follow-Up Studies ; Heart failure ; Heart rate ; Heart Rate - physiology ; Hospitalization ; Humans ; Hypertension ; Hypoxia ; Kidney diseases ; Laboratories ; Male ; Middle Aged ; Retrospective Studies ; Sinuses ; Stroke ; Studies ; Treatment Outcome ; Variables</subject><ispartof>The American journal of cardiology, 2015-05, Vol.115 (10), p.1407-1414</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited May 15, 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3</citedby><cites>FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3</cites><orcidid>0000-0002-4729-7820</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25784514$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Steinberg, Benjamin Adam, MD, MHS</creatorcontrib><creatorcontrib>Schulte, Phillip Joel, PhD</creatorcontrib><creatorcontrib>Hofmann, Paul, BS</creatorcontrib><creatorcontrib>Ersbøll, Mads, MD</creatorcontrib><creatorcontrib>Alexander, John Hunter, MD, MHS</creatorcontrib><creatorcontrib>Broderick-Forsgren, Kathleen, MD</creatorcontrib><creatorcontrib>Anstrom, Kevin Joseph, PhD</creatorcontrib><creatorcontrib>Granger, Christopher Bull, MD</creatorcontrib><creatorcontrib>Piccini, Jonathan Paul, MD, MHS</creatorcontrib><creatorcontrib>Velazquez, Eric Jose, MD</creatorcontrib><creatorcontrib>Shah, Bimal Ramesh, MD, MBA</creatorcontrib><title>Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Electrical cardioversion (ECV) is recommended for rhythm control in patients with atrial arrhythmia; yet, ECV use and outcomes in contemporary practice are unknown. We reviewed all nonemergent ECVs for atrial arrhythmias at a tertiary care center (2010 to 2013), stratifying patients by transesophageal echocardiography (TEE) use before ECV and comparing demographics, history, vitals, and laboratory studies. Outcomes included postprocedural success and complications and repeat cardioversion, rehospitalization, and death within 30 days. Overall, 1,017 patients underwent ECV, 760 (75%) for atrial fibrillation and 240 (24%) for atrial flutter; 633 underwent TEE before ECV and 384 did not. TEE recipients were more likely to be inpatients (74% vs 44%, p &lt;0.001), have higher mean CHADS2 scores (2.6 vs 2.4, p = 0.03), and lower mean international normalized ratios (1.2 vs 2.1, p &lt;0.001). Overall, 89 patients (8.8%) did not achieve sinus rhythm and 14 experienced procedural complications (1.4%). Within 30 days, 80 patients (7.9%) underwent repeat ECV, 113 (11%) were rehospitalized, and 14 (1.4%) died. Although ECV success was more common in patients who underwent TEE before ECV (77% vs 68%, p = 0.01), there were no differences in 30-day death or rehospitalization rates (11.1% vs 13.0%, p = 0.37). In multivariate analyses, higher pre-ECV heart rate was associated with increased rehospitalization or death (adjusted hazard ratio 1.15/10 beats/min, 95% confidence interval 1.07 to 1.24, p &lt;0.001), whereas TEE use was associated with lower rates (adjusted hazard ratio 0.58, 95% confidence interval 0.39 to 0.86, p = 0.007). In conclusion, failures, complications, and rehospitalization after nonemergent ECV are common and associated more with patient condition than procedural characteristics. TEE use was associated with better clinical outcomes.</description><subject>Age</subject><subject>Aged</subject><subject>Atrial Fibrillation - diagnostic imaging</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - therapy</subject><subject>Blood pressure</subject><subject>Cardiac arrhythmia</subject><subject>Cardiovascular</subject><subject>Cardiovascular disease</subject><subject>Clinical outcomes</subject><subject>Confidence intervals</subject><subject>Diabetes</subject><subject>Echocardiography, Transesophageal</subject><subject>Electric Countershock - methods</subject><subject>Emergencies</subject><subject>Family medical history</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart failure</subject><subject>Heart rate</subject><subject>Heart Rate - physiology</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Hypertension</subject><subject>Hypoxia</subject><subject>Kidney diseases</subject><subject>Laboratories</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Sinuses</subject><subject>Stroke</subject><subject>Studies</subject><subject>Treatment Outcome</subject><subject>Variables</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNqFkcFu1DAQhi0EosvCI4Aiceklqcex4_hStFoVaFXRA3C2vM6EOk3iYieV9u1xtEsr9dKTZc03M_b3E_IRaAEUqrOuMENnTWgKRkEUlBW0pK_ICmqpclBQviYrSinLFXB1Qt7F2KUrgKjekhMmZM0F8BW5upkn6weM2aadMGQ__IgDhj84TtlFj3YKzpo-26ZFzj9giM6PWetDtkmVVNiEcLufbgdn4nvypjV9xA_Hc01-f734tf2eX998u9xurnMrKjHlqJQs0TRUcaQcGstaA4zZVlY1NKoVtQEqdqoSZSvUjpsGOCbK7oBLI7Fck9PD3Pvg_84YJz24aLHvzYh-jhoqKUupykol9PMztPNzGNPrElWD4LJOa9ZEHCgbfIwBW30f3GDCXgPVi2zd6aNsvcjWlOkkO_V9Ok6fdwM2j13_7SbgywHApOPBYdDROhwtNi4ktbrx7sUV588m2N6NSyR3uMf49BsdU4P-uSS-BA6CUskqVv4Du-CnEA</recordid><startdate>20150515</startdate><enddate>20150515</enddate><creator>Steinberg, Benjamin Adam, MD, MHS</creator><creator>Schulte, Phillip Joel, PhD</creator><creator>Hofmann, Paul, BS</creator><creator>Ersbøll, Mads, MD</creator><creator>Alexander, John Hunter, MD, MHS</creator><creator>Broderick-Forsgren, Kathleen, MD</creator><creator>Anstrom, Kevin Joseph, PhD</creator><creator>Granger, Christopher Bull, MD</creator><creator>Piccini, Jonathan Paul, MD, MHS</creator><creator>Velazquez, Eric Jose, MD</creator><creator>Shah, Bimal Ramesh, MD, MBA</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4729-7820</orcidid></search><sort><creationdate>20150515</creationdate><title>Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias</title><author>Steinberg, Benjamin Adam, MD, MHS ; Schulte, Phillip Joel, PhD ; Hofmann, Paul, BS ; Ersbøll, Mads, MD ; Alexander, John Hunter, MD, MHS ; Broderick-Forsgren, Kathleen, MD ; Anstrom, Kevin Joseph, PhD ; Granger, Christopher Bull, MD ; Piccini, Jonathan Paul, MD, MHS ; Velazquez, Eric Jose, MD ; Shah, Bimal Ramesh, MD, MBA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Age</topic><topic>Aged</topic><topic>Atrial Fibrillation - diagnostic imaging</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - therapy</topic><topic>Blood pressure</topic><topic>Cardiac arrhythmia</topic><topic>Cardiovascular</topic><topic>Cardiovascular disease</topic><topic>Clinical outcomes</topic><topic>Confidence intervals</topic><topic>Diabetes</topic><topic>Echocardiography, Transesophageal</topic><topic>Electric Countershock - methods</topic><topic>Emergencies</topic><topic>Family medical history</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart failure</topic><topic>Heart rate</topic><topic>Heart Rate - physiology</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Hypertension</topic><topic>Hypoxia</topic><topic>Kidney diseases</topic><topic>Laboratories</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Sinuses</topic><topic>Stroke</topic><topic>Studies</topic><topic>Treatment Outcome</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Steinberg, Benjamin Adam, MD, MHS</creatorcontrib><creatorcontrib>Schulte, Phillip Joel, PhD</creatorcontrib><creatorcontrib>Hofmann, Paul, BS</creatorcontrib><creatorcontrib>Ersbøll, Mads, MD</creatorcontrib><creatorcontrib>Alexander, John Hunter, MD, MHS</creatorcontrib><creatorcontrib>Broderick-Forsgren, Kathleen, MD</creatorcontrib><creatorcontrib>Anstrom, Kevin Joseph, PhD</creatorcontrib><creatorcontrib>Granger, Christopher Bull, MD</creatorcontrib><creatorcontrib>Piccini, Jonathan Paul, MD, MHS</creatorcontrib><creatorcontrib>Velazquez, Eric Jose, MD</creatorcontrib><creatorcontrib>Shah, Bimal Ramesh, MD, MBA</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Steinberg, Benjamin Adam, MD, MHS</au><au>Schulte, Phillip Joel, PhD</au><au>Hofmann, Paul, BS</au><au>Ersbøll, Mads, MD</au><au>Alexander, John Hunter, MD, MHS</au><au>Broderick-Forsgren, Kathleen, MD</au><au>Anstrom, Kevin Joseph, PhD</au><au>Granger, Christopher Bull, MD</au><au>Piccini, Jonathan Paul, MD, MHS</au><au>Velazquez, Eric Jose, MD</au><au>Shah, Bimal Ramesh, MD, MBA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2015-05-15</date><risdate>2015</risdate><volume>115</volume><issue>10</issue><spage>1407</spage><epage>1414</epage><pages>1407-1414</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Electrical cardioversion (ECV) is recommended for rhythm control in patients with atrial arrhythmia; yet, ECV use and outcomes in contemporary practice are unknown. We reviewed all nonemergent ECVs for atrial arrhythmias at a tertiary care center (2010 to 2013), stratifying patients by transesophageal echocardiography (TEE) use before ECV and comparing demographics, history, vitals, and laboratory studies. Outcomes included postprocedural success and complications and repeat cardioversion, rehospitalization, and death within 30 days. Overall, 1,017 patients underwent ECV, 760 (75%) for atrial fibrillation and 240 (24%) for atrial flutter; 633 underwent TEE before ECV and 384 did not. TEE recipients were more likely to be inpatients (74% vs 44%, p &lt;0.001), have higher mean CHADS2 scores (2.6 vs 2.4, p = 0.03), and lower mean international normalized ratios (1.2 vs 2.1, p &lt;0.001). Overall, 89 patients (8.8%) did not achieve sinus rhythm and 14 experienced procedural complications (1.4%). Within 30 days, 80 patients (7.9%) underwent repeat ECV, 113 (11%) were rehospitalized, and 14 (1.4%) died. Although ECV success was more common in patients who underwent TEE before ECV (77% vs 68%, p = 0.01), there were no differences in 30-day death or rehospitalization rates (11.1% vs 13.0%, p = 0.37). In multivariate analyses, higher pre-ECV heart rate was associated with increased rehospitalization or death (adjusted hazard ratio 1.15/10 beats/min, 95% confidence interval 1.07 to 1.24, p &lt;0.001), whereas TEE use was associated with lower rates (adjusted hazard ratio 0.58, 95% confidence interval 0.39 to 0.86, p = 0.007). In conclusion, failures, complications, and rehospitalization after nonemergent ECV are common and associated more with patient condition than procedural characteristics. TEE use was associated with better clinical outcomes.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25784514</pmid><doi>10.1016/j.amjcard.2015.02.030</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4729-7820</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2015-05, Vol.115 (10), p.1407-1414
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1677379369
source ScienceDirect Journals
subjects Age
Aged
Atrial Fibrillation - diagnostic imaging
Atrial Fibrillation - physiopathology
Atrial Fibrillation - therapy
Blood pressure
Cardiac arrhythmia
Cardiovascular
Cardiovascular disease
Clinical outcomes
Confidence intervals
Diabetes
Echocardiography, Transesophageal
Electric Countershock - methods
Emergencies
Family medical history
Female
Follow-Up Studies
Heart failure
Heart rate
Heart Rate - physiology
Hospitalization
Humans
Hypertension
Hypoxia
Kidney diseases
Laboratories
Male
Middle Aged
Retrospective Studies
Sinuses
Stroke
Studies
Treatment Outcome
Variables
title Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T05%3A51%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Outcomes%20After%20Nonemergent%20Electrical%20Cardioversion%20for%20Atrial%20Arrhythmias&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Steinberg,%20Benjamin%20Adam,%20MD,%20MHS&rft.date=2015-05-15&rft.volume=115&rft.issue=10&rft.spage=1407&rft.epage=1414&rft.pages=1407-1414&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2015.02.030&rft_dat=%3Cproquest_cross%3E3688538991%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c565t-e9973ead094e041dc2fa122cf7681d9f58a105b9653f59b4ad14edc2cb147a7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1681547865&rft_id=info:pmid/25784514&rfr_iscdi=true